Net gamma exposure for Alkermes Inc plc (ALKS) options was positive at the Nov 4, 2026 close, about $263.95K per 1% move in the stock. It has been positive on 12 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for ALKS, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for ALKS, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for ALKS, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
ALKS Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is ALKS gamma exposure positive or negative?
Alkermes net gamma exposure was positive on Nov 4, 2026, at $263.95K. It has been positive on 12 of the last 20 trading days.
How has ALKS gamma exposure changed recently?
Alkermes net gamma exposure went from -$314.63K on Oct 7, 2026 to $263.95K on Nov 4, 2026. That is its highest reading in 8 weeks. See the ALKS gamma exposure history for a longer view.
What is Alkermes Inc plc?
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas.